Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bustelo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|May 4, 1996
A tranquil city with a high tranquilliser intakeP Bustelo, J Mari, C Fernández, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1996
Glanzmann thrombasthenia in children from ArgentinaB Sassetti, A Lajmanovich, A Vázquez, et al.
Cancer Treatment Reports|May 1, 1983
Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapseS Pavlovsky, F S Muriel, M Eppinger-Helft, et al.
Sangre|June 1, 1989
[Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987]D Freigeiro, C Scaglione, M T Santarelli, et al.
Cancer Treatment Reports|April 1, 1984
Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemiaF Sackmann Muriel, E Svarch, S Pavlovsky, et al.
Medicina|January 1, 1981
[Treatment of acute lymphoblastic leukemia. Results with 1,192 patients]F Sackmann Muriel, P Bustelo, S Pavlovsky, et al.
Medicina Intensiva|April 24, 2022
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective studyÁ Estella, J L Garcia Garmendia, C de la Fuente, et al.
Medicina Intensiva|April 4, 2021
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective studyÁ Estella, J L Garcia Garmendia, C de la Fuente, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|May 4, 1996
A tranquil city with a high tranquilliser intakeP Bustelo, J Mari, C Fernández, et al.
Journal of Pediatric Hematology/Oncology|February 1, 1996
Glanzmann thrombasthenia in children from ArgentinaB Sassetti, A Lajmanovich, A Vázquez, et al.
Cancer Treatment Reports|May 1, 1983
Daunorubicin, vincristine, and prednisone for remission induction in patients with acute lymphoblastic leukemia in relapseS Pavlovsky, F S Muriel, M Eppinger-Helft, et al.
Sangre|June 1, 1989
[Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987]D Freigeiro, C Scaglione, M T Santarelli, et al.
Cancer Treatment Reports|April 1, 1984
Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemiaF Sackmann Muriel, E Svarch, S Pavlovsky, et al.
Medicina|January 1, 1981
[Treatment of acute lymphoblastic leukemia. Results with 1,192 patients]F Sackmann Muriel, P Bustelo, S Pavlovsky, et al.
Medicina Intensiva|April 24, 2022
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective studyÁ Estella, J L Garcia Garmendia, C de la Fuente, et al.
Medicina Intensiva|April 4, 2021
Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective studyÁ Estella, J L Garcia Garmendia, C de la Fuente, et al.
Pageof 1